Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC).

作者: Sven Wagner , Tim Fueller , Vera Hummel , Peter Rieckmann , Joerg-Christian Tonn

DOI: 10.1023/A:1023335732264

关键词: Cell cultureImmunologyMotilityEndotheliumCancer researchUmbilical veinNeovascularizationCell typeBiologyEndothelial stem cellCell

摘要: Neovascularization and invasion are key features of malignant gliomas. Matrix metalloproteinases (MMPs) supposed to play a major role mediating these processes. To analyze the expression patterns MMPs in microvascular human cerebral endothelial cells (HCEC), we isolated from normal brain microvessels. Characterization cellular origin was performed by immunostaining, using cell markers Ulex europaeus Agglutinin-1, von-Willebrand-Factor Glucose-transporter-1. Contamination other types tracked immunohistochemistry for GFAP (astrocytes), ASM (pericytes) CD68 (macrophages). Secretion evaluated ELISA zymography. determine whether HCEC show any difference MMP compared analyzed umbilical vein (HUVEC). decrease MMP-3 MMP-2 protein when treated with SU5416, VEGF-R2 (KDR/flk-1) inhibitor, whereas remained unchanged HUVEC. findings effect motility used three-dimensional co-culture assay avascular glioblastoma spheroids primary spheroids. Untreated controls showed both populations into each treatment co-cultures SU5416 resulted complete inhibition hence indicating that flk-1 related is critically involved this process can be studied assay. The results different effects anti-angiogenic on proteolytic properties two suggest neovascularization tumors vitro dependent surrounding type should therefore organ-specific cells.

参考文章(45)
Roland H. Goldbrunner, Sven Wagner, Klaus Roosen, Joerg-Christian Tonn, Models for assessment of angiogenesis in gliomas. Journal of Neuro-oncology. ,vol. 50, pp. 53- 62 ,(2000) , 10.1023/A:1006462504447
R Hanemaaijer, P Koolwijk, L le Clercq, W J A de Vree, V W M van Hinsbergh, Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α, interleukin 1 and phorbol ester Biochemical Journal. ,vol. 296, pp. 803- 809 ,(1993) , 10.1042/BJ2960803
Meng-Chun Jia, Martin A. Schwartz, QingXiang Amy Sang, Suppression of Human Microvascular Endothelial Cell Invasion and Morphogenesis With Synthetic Matrixin Inhibitors Advances in Experimental Medicine and Biology. ,vol. 476, pp. 181- 194 ,(2000) , 10.1007/978-1-4615-4221-6_15
Shizuo Shirai, Shingo Takano, Hideo Suzuki, Shinichi Kondo, Tooru Maruno, Yoshihiko Yoshii, Tadao Nose, Concentration of Vascular Endothelial Growth Factor in the Serum and Tumor Tissue of Brain Tumor Patients Cancer Research. ,vol. 56, pp. 2185- 2190 ,(1996)
R M Shaheen, L M Ellis, C Liang, S Weitman, A L Hannah, J M Cherrington, L K Shawver, B D Smolich, D B Mendel, A D Laird, R A Blake, Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anti-cancer Drug Design. ,vol. 15, pp. 29- 41 ,(2000)
Douglas Hanahan, Signaling Vascular Morphogenesis and Maintenance Science. ,vol. 277, pp. 48- 50 ,(1997) , 10.1126/SCIENCE.277.5322.48
Gabriele Bergers, Rolf Brekken, Gerald McMahon, Thiennu H. Vu, Takeshi Itoh, Kazuhiko Tamaki, Kazuhiko Tanzawa, Philip Thorpe, Shigeyoshi Itohara, Zena Werb, Douglas Hanahan, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology. ,vol. 2, pp. 737- 744 ,(2000) , 10.1038/35036374
Frances Maher, Susan J. Vannucci, Ian A. Simpson, Glucose transporter proteins in brain. The FASEB Journal. ,vol. 8, pp. 1003- 1011 ,(1994) , 10.1096/FASEBJ.8.13.7926364
Rosalba Salcedo, James H. Resau, Douglas Halverson, Eric A. Hudson, Michael Dambach, Douglas Powell, Ken Wasserman, Joost J. Oppenheim, Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells The FASEB Journal. ,vol. 14, pp. 2055- 2064 ,(2000) , 10.1096/FJ.99-0963COM